Actoxumab

DB16376InvestigationalProtein Based Therapies

Actoxumab is under investigation in clinical trial NCT01241552 (A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)).

Mechanism: Pharmacologically active on Toxin A
Curator reviewed
Code names: GS-CDA1 · MDX-066 · MK-3415

Resolves to

Compound

UNIIG3LU5LC5SXCAS1245634-25-6

Targets

P16154tcdA

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Actoxumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account